Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Structure and Assembly

In Vitro Recoating of Reovirus Cores with Baculovirus-Expressed Outer-Capsid Proteins μ1 and ς3

Kartik Chandran, Stephen B. Walker, Ya Chen, Carlo M. Contreras, Leslie A. Schiff, Timothy S. Baker, Max L. Nibert
Kartik Chandran
Department of Biochemistry,
Institute for Molecular Virology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen B. Walker
Department of Biological Sciences, Purdue University, West Lafayette, Indiana 47907; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ya Chen
Integrated Microscopy Resource, University of Wisconsin—Madison, Madison, Wisconsin 53706;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlo M. Contreras
Department of Biochemistry,
Institute for Molecular Virology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leslie A. Schiff
Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy S. Baker
Department of Biological Sciences, Purdue University, West Lafayette, Indiana 47907; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Max L. Nibert
Department of Biochemistry,
Institute for Molecular Virology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.73.5.3941-3950.1999
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    In vitro assembly of baculovirus-expressed μ1 and ς3 proteins onto reovirus cores. (A) [35S]methionine/cysteine-labeled cytoplasmic extract prepared from 7.5 × 107 Tn High Five cells infected with a μ1- and ς3-expressing recombinant baculovirus was incubated with unlabeled reovirus cores (5 × 1012 particles). The resulting r-core particles were purified on two successive CsCl gradients. Both the extract (lane 1) and the purified r-cores (lane 2) were subjected to SDS-PAGE and phosphor imaging.35S-labeled cores (Core) and virions (Virion) were included as markers to indicate positions of the viral proteins. (B) Two independent preparations of purified r-cores (R-core 1 and R-core 2), generated as described above except by using unlabeled insect cell extract, were examined by SDS-PAGE and Coomassie blue staining. A lane of purified virions was included for comparison. (C) Purified cores, virions, and r-cores were examined by tricine-SDS-PAGE (44) on a 10 to 16% acrylamide gradient gel and Coomassie blue staining. Only those portions of the gel containing μ1 and its fragments are shown. Positions of molecular weight markers are indicated by Mr (103) at the left.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Cryo-SEM of purified r-cores and pr-cores. Low-magnification (×150,000) images of cores (A), r-cores (B), and pr-cores (C) and high-magnification (×500,000) images of r-cores (D) and pr-cores (E) are shown. The particles in panels D and E are oriented near an axis of twofold symmetry. The scale bar in panel A applies to panels A to C, while that in panel E applies to panels D to E.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Image reconstructions of r-cores from cryo-TEM images. The reconstruction of r-cores (C and F; 24 Å) is compared with previously reported reconstructions of cores (A and D; 32 Å) and virions (B and E; 28 Å) (15). (A to C) Surface-shaded views down a twofold axis of symmetry for each particle. (D to F) Same views as in panels A to C except that the reconstructions were radially cropped to remove all densities below 321 Å, thereby isolating features attributable to outer-capsid proteins μ1, ς3, ς1, and λ2 in the display.

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Close-up surface-shaded views of the λ2 turret in r-cores. The reconstructions of r-cores (C and F), cores (A and D), and virions (B and E) are shown in close-up for a representative λ2 turret. Asterisks indicate one of the five petal-like elements that form the central λ2 flower in virions and r-cores and then move outward and upward during conversion of virions to cores. Triangles in panels B and E indicate the drop-like density in virions attributed to ς1 that is absent in the r-core reconstruction. (A to C) Top views. (D to F) Views generated by tilting images by 45° about the horizontal axis. Images were sectioned so as to permit a clear view of the λ2 turret.

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Proteolytic processing of r-cores to pr-cores by CHT. Viral proteins were visualized by SDS-PAGE and Coomassie blue staining. (A) Purified virions or r-cores were treated with CHT for 1 h, and the resulting ISVPs or pr-cores were purified by centrifugation through CsCl density gradients. Viral proteins were resolved on a 5 to 20% acrylamide gradient gel (39). Positions of molecular weight markers are indicated by Mr (103) at the right. A lane of purified cores was included for comparison. (B) Purified virions were treated with CHT for specified times. A marker lane of untreated virions was included for comparison (M). (C) Same as panel B except that purified r-cores were used instead of virions.

  • Fig. 6.
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Capacity of pr-cores to induce lysis of RBCs in vitro. Bovine calf RBCs (final concentration, 3% [vol/vol]; Colorado Serum Co., Denver, Colo.) were incubated with purified virions, r-cores, cores, or CHT treatment mixtures containing ISVPs or pr-cores (3 × 1012 particles/ml) at 37°C for 40 min in the presence of CsCl (200 mM). Reactions were terminated by removal onto ice, and RBCs were pelleted by centrifugation at 300 × g for 5 min. The extent of hemolysis in each reaction was determined by measuring A415 of the supernatant and was expressed as a percentage (hemolysis by distilled water = 100%). Each bar represents the mean ± SD from three trials.

  • Fig. 7.
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Capacity of ς1-specific and core-specific antibodies to neutralize infectivity of cores and r-cores. Purified virions, cores, r-cores, or CHT treatment mixtures containing ISVPs or pr-cores were incubated with a ς1-specific MAb (5C6), a core-specific antiserum (anticore), or phosphate-buffered saline. Virus-antibody mixtures were used to infect L-cell monolayers, and infectious titers were measured by plaque assay. Neutralization of infectivity was expressed as the percentage of plaques remaining after antibody treatment. Each bar represents the mean plaque survival ± SD derived from three independent experiments for 5C6 treatment. Overlaid bars represent values from two experiments with the core-specific antiserum.

  • Fig. 8.
    • Open in new tab
    • Download powerpoint
    Fig. 8.

    Capacity of r-cores to replicate in the absence and presence of inhibitors of viral infectivity. Purified virions, cores, r-cores, or CHT treatment mixtures containing ISVPs or pr-cores were used to infect L-cell monolayers at an MOI of 0.01 PFU/cell in the absence of inhibitor (solid bars) or presence of 20 mM NH4Cl (hatched bars) or 300 μM E-64 (gray bars) in the growth medium. Infectious titers at times 0 and 24 h were measured by plaque assay. Each bar represents the mean [log10(PFU/ml)t = 24 h − log10(PFU/ml)t = 0] ± SD derived from three independent experiments for no inhibitor and NH4Cl treatments. Overlaid bars represent values from two experiments for E-64 treatment.

  • Fig. 9.
    • Open in new tab
    • Download powerpoint
    Fig. 9.

    Generation of pr-cores(μ1-581D) and measurement of their capacity to induce lysis of RBCs and to initiate infection. (A) Purified r-cores(μ1-581D) or r-cores(μ1-581Y) were incubated with TLCK-treated CHT or TPCK-treated TRY to generate pr-cores(μ1-581D) or pr-cores(μ1-581Y), respectively. Viral proteins were resolved by SDS-PAGE and visualized by Coomassie blue staining. A marker lane of untreated r-cores(μ1-581D) or r-cores(μ1-581Y) was loaded onto each gel for comparison (M). (B) Purified r-cores(μ1-581D) or CHT treatment mixtures containing pr-cores(μ1-581D) or pr-cores(μ1-581Y) (2 × 1012 particles/ml) were incubated with bovine calf RBCs at 37°C for 30 min in the presence of CsCl, and the extent of hemolysis induced by each virus preparation was measured as described for Fig. 6. Each bar represents the mean ± SD from three trials except in the case of r-cores(μ1-581D) where two trials were performed, and the average of both is shown. The extent of hemolysis was lower than that in Fig. 6 because a lower concentration of particles was used. (C) The capacity of purified r-cores(μ1-581D) or CHT treatment mixtures containing pr-cores(μ1-581D) to replicate in L cells over a 24 h-period in the absence (solid bars) or presence (hatched bars) of 20 mM NH4Cl was determined from three independent experiments as described for Fig. 8. An MOI of 0.01 PFU/cell was used.

Tables

  • Figures
  • Table 1.

    Quantitation of μ1C and ς3 proteins in r-coresa

    Particle typePrepnλ/μ1Cbς3/μ1Cb
    Virion10.67 ± 0.020.78 ± 0.03
    20.59 ± 0.030.77 ± 0.06
    r-core10.67 ± 0.030.76 ± 0.02
    2c 0.68 ± 0.030.81 ± 0.03
    30.65 ± 0.030.72 ± 0.06
    r-core(μ1-581D)10.60 ± 0.060.73 ± 0.06
    • ↵a See text for descriptions of r-cores.

    • ↵b Volume-based intensities of the λ, μ1C, and ς3 protein bands were determined by densitometry of Coomassie blue-stained SDS-polyacrylamide gels on which the proteins from purified particles were separated. Band ratios were calculated from three different lanes for each particle preparation. Mean ± SD of the three values is reported.

    • ↵c Same as r-core preparation 2 in Fig. 1B and preparation B-2 in Table 2.

  • Table 2.

    Infectivity of purified r-coresa

    Particle typePrepnbP/PFUcRelative P/PFUd
    CoreA1.1 × 109 1.0
    B5.0 × 108 1.0
    r-coreA-12.1 × 106 530
    A-22.3 × 106 480
    B-11.4 × 106 360
    B-2e 1.1 × 106 450
    r-core(μ1-581D)B-11.9 × 106 260
    Virion11507.3 × 106
    21109.7 × 106
    • ↵a See text for descriptions of r-cores.

    • ↵b Each core preparation is designated with a capital letter. Each r-core preparation is designated with a letter, representing the core preparation from which it was derived, followed by the preparation number.

    • ↵c Particle (P) per PFU values for each preparation were obtained by dividing P per milliliter by PFU per milliliter and are presented as an average of three determinations (SD < 0.10 log10 unit for all values). Concentrations of virion and core preparations were estimated by A260 (13, 51). Concentrations of r-core preparations were determined by densitometry of Coomassie blue-stained SDS-polyacrylamide gels compared with virion standards. Viral infectivity was measured by plaque assay (18).

    • ↵d Defined as the ratio of P/PFU value of a preparation of cores to P/PFU value of a matching core or r-core preparation. Relative P/PFU values of virion preparations were calculated by using the PFU-per-milliliter value of core preparation A.

    • ↵e Same as r-core preparation 2 in Fig. 1B and Table 1.

PreviousNext
Back to top
Download PDF
Citation Tools
In Vitro Recoating of Reovirus Cores with Baculovirus-Expressed Outer-Capsid Proteins μ1 and ς3
Kartik Chandran, Stephen B. Walker, Ya Chen, Carlo M. Contreras, Leslie A. Schiff, Timothy S. Baker, Max L. Nibert
Journal of Virology May 1999, 73 (5) 3941-3950; DOI: 10.1128/JVI.73.5.3941-3950.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
In Vitro Recoating of Reovirus Cores with Baculovirus-Expressed Outer-Capsid Proteins μ1 and ς3
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
In Vitro Recoating of Reovirus Cores with Baculovirus-Expressed Outer-Capsid Proteins μ1 and ς3
Kartik Chandran, Stephen B. Walker, Ya Chen, Carlo M. Contreras, Leslie A. Schiff, Timothy S. Baker, Max L. Nibert
Journal of Virology May 1999, 73 (5) 3941-3950; DOI: 10.1128/JVI.73.5.3941-3950.1999
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514